Cannabis microdosing — the knowledge hub

Legal framework and fitness to drive in Switzerland

In Switzerland, the microdosing of THC-containing cannabis is subject to strict legal guidelines. Although medical cannabis has been directly prescribable by doctors without an exceptional permit from the BAG since August 2022, a strict zero-tolerance practice applies to road traffic. The limit value of 1.5 micrograms of THC per liter of blood means that even minimal, sub-intoxicating doses can lead to proven unfitness to drive. Anyone who microdoses cannabis must be aware that legal fitness to drive is void, regardless of the subjective feeling of intoxication.

For the non-medical sector, the ongoing pilot trials in various Swiss cities offer controlled access to regulated products. Outside of these scientific projects, the purchase and possession of cannabis with a total THC content of over one percent is illegal, and consumption can be punished with an administrative fine of 100 CHF. Anyone looking for legal alternatives can turn to CBD products containing less than one percent THC. These are not subject to the Narcotics Act, but also allow precise dosing in the milligram range thanks to standardized extracts.

• Medical prescription of medical cannabis simplified since August 2022.
• Strict zero tolerance in road traffic with a limit value of 1.5 µg/L blood.
• Regulated sourcing for scientific purposes is possible via cantonal pilot trials.
• Legal CBD products must have a total THC content of under one percent.

Physiological mechanisms and receptor regulation

The effect of microdosing is based on the interaction of phytocannabinoids with the body's own endocannabinoid system. At the center is the CB1 receptor, which is widely distributed in the central nervous system. While high doses of tetrahydrocannabinol lead to rapid internalization and downregulation of these receptors, which manifests as the development of tolerance, microdosing aims for a subtle stimulation. Due to the small amount of active ingredient, receptor density remains stable, thereby preserving the sensitivity of the system in the long term and minimizing habituation effects.

In addition to direct receptor binding, micro-amounts of cannabinoids also influence the release of neurotransmitters such as dopamine and gamma-aminobutyric acid. This fine modulation can support regulatory processes in the body without disrupting the physiological balance. Since the available data on the long-term use of microdoses is still limited, therapists rely primarily on the principle of gradual dose adjustment. The goal is to make optimal use of the therapeutic window in which positive effects occur before undesirable side effects or cognitive impairments become noticeable.

• Preserving CB1 receptors prevents the rapid development of tolerance.
• Subtle modulation of neurotransmitters without profound disruption of the balance.
• Utilization of the narrow therapeutic window through systematic dose adjustment.
• Scientific evidence is predominantly based on preclinical models and case reports.

Forms of administration and precise titration

For successful microdosing, choosing the right form of administration is crucial, as bioavailability and effect curves differ drastically. Oral forms such as standardized oils or tinctures are particularly suitable, as they allow for precise droplet dosing using pipettes. Although the onset of action is delayed, it lasts for several hours, which is advantageous for continuous support in everyday life. It is important to consider the first-pass effect in the liver, which metabolizes the active ingredient.

In contrast, inhalation via vaporizers with precise temperature control allows for almost immediate feedback from the body. Through short, controlled puffs, the amount consumed can be finely adjusted, which minimizes the risk of overdosing. However, determining the exact milligram amount inhaled is more difficult than with oral preparations. Regardless of the method, the therapeutic principle remains to start with the lowest possible dose and increase it only minimally over several days.

• Oils and tinctures enable precise milligram dosing via the number of drops.
• Inhalation offers rapid onset of action and direct control over intensity.
• First-pass metabolism during oral ingestion significantly extends the duration of action.
• Systematically keeping a dosing journal supports the determination of the individual dose.

FAQ